Literature DB >> 25747532

The role of viral, host, and secondary bacterial factors in influenza pathogenesis.

John C Kash1, Jeffery K Taubenberger2.   

Abstract

Influenza A virus infections in humans generally cause self-limited infections, but can result in severe disease, secondary bacterial pneumonias, and death. Influenza viruses can replicate in epithelial cells throughout the respiratory tree and can cause tracheitis, bronchitis, bronchiolitis, diffuse alveolar damage with pulmonary edema and hemorrhage, and interstitial and airspace inflammation. The mechanisms by which influenza infections result in enhanced disease, including development of pneumonia and acute respiratory distress, are multifactorial, involving host, viral, and bacterial factors. Host factors that enhance risk of severe influenza disease include underlying comorbidities, such as cardiac and respiratory disease, immunosuppression, and pregnancy. Viral parameters enhancing disease risk include polymerase mutations associated with host switch and adaptation, viral proteins that modulate immune and antiviral responses, and virulence factors that increase disease severity, which can be especially prominent in pandemic viruses and some zoonotic influenza viruses causing human infections. Influenza viral infections result in damage to the respiratory epithelium that facilitates secondary infection with common bacterial pneumopathogens and can lead to secondary bacterial pneumonias that greatly contribute to respiratory distress, enhanced morbidity, and death. Understanding the molecular mechanisms by which influenza and secondary bacterial infections, coupled with the role of host risk factors, contribute to enhanced morbidity and mortality is essential to develop better therapeutic strategies to treat severe influenza. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25747532      PMCID: PMC4450310          DOI: 10.1016/j.ajpath.2014.08.030

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

1.  Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Authors:  Niall P A S Johnson; Juergen Mueller
Journal:  Bull Hist Med       Date:  2002       Impact factor: 1.314

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  A novel cytotoxic sequence contributes to influenza A viral protein PB1-F2 pathogenicity and predisposition to secondary bacterial infection.

Authors:  Irina V Alymova; Amali Samarasinghe; Peter Vogel; Amanda M Green; Ricardo Weinlich; Jonathan A McCullers
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

4.  Pulmonary staphylococcal complications in patients during the influenza epidemic in 1971-1972.

Authors:  K Kostrzewska; W Massalski; B Narbutowicz; W Zielinski
Journal:  Mater Med Pol       Date:  1974 Jul-Sep

5.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Kimberly C Bartmess
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

6.  The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding.

Authors:  Li Qi; John C Kash; Vivien G Dugan; Brett W Jagger; Yuk-Fai Lau; Zhong-Mei Sheng; Erika C Crouch; Kevan L Hartshorn; Jeffery K Taubenberger
Journal:  Virology       Date:  2011-02-18       Impact factor: 3.616

7.  Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus.

Authors:  Claudia Pappas; Patricia V Aguilar; Christopher F Basler; Alicia Solórzano; Hui Zeng; Lucy A Perrone; Peter Palese; Adolfo García-Sastre; Jacqueline M Katz; Terrence M Tumpey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

Review 8.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

9.  Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.

Authors:  John C Kash; Kathie-Anne Walters; A Sally Davis; Aline Sandouk; Louis M Schwartzman; Brett W Jagger; Daniel S Chertow; Qi Li; Rolf E Kuestner; Adrian Ozinsky; Jeffery K Taubenberger
Journal:  mBio       Date:  2011-09-20       Impact factor: 7.867

10.  The evolutionary genetics and emergence of avian influenza viruses in wild birds.

Authors:  Vivien G Dugan; Rubing Chen; David J Spiro; Naomi Sengamalay; Jennifer Zaborsky; Elodie Ghedin; Jacqueline Nolting; David E Swayne; Jonathan A Runstadler; George M Happ; Dennis A Senne; Ruixue Wang; Richard D Slemons; Edward C Holmes; Jeffery K Taubenberger
Journal:  PLoS Pathog       Date:  2008-05-30       Impact factor: 6.823

View more
  71 in total

1.  A Call for Greater Consideration for the Role of Vaccines in National Strategies to Combat Antibiotic-Resistant Bacteria: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 10, 2015.

Authors: 
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

2.  Whole genome sequencing identifies influenza A H3N2 transmission and offers superior resolution to classical typing methods.

Authors:  Dominik M Meinel; Susanne Heinzinger; Ute Eberle; Nikolaus Ackermann; Katharina Schönberger; Andreas Sing
Journal:  Infection       Date:  2017-10-31       Impact factor: 3.553

3.  The Mother of All Pandemics Is 100 Years Old (and Going Strong)!

Authors:  David M Morens; Jeffery K Taubenberger
Journal:  Am J Public Health       Date:  2018-09-25       Impact factor: 9.308

Review 4.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

Review 5.  Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.

Authors:  David S Fedson
Journal:  Ann Transl Med       Date:  2016-11

Review 6.  The role of vaccines in preventing bacterial antimicrobial resistance.

Authors:  Kathrin U Jansen; Charles Knirsch; Annaliesa S Anderson
Journal:  Nat Med       Date:  2018-01-09       Impact factor: 53.440

7.  Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia.

Authors:  Sivasami Pulavendran; Jennifer M Rudd; Prasanthi Maram; Paul G Thomas; Ramachandran Akhilesh; Jerry R Malayer; Vincent T K Chow; Narasaraju Teluguakula
Journal:  Am J Respir Cell Mol Biol       Date:  2019-12       Impact factor: 6.914

8.  Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury.

Authors:  Terren K Niethamer; Collin T Stabler; John P Leach; Jarod A Zepp; Michael P Morley; Apoorva Babu; Su Zhou; Edward E Morrisey
Journal:  Elife       Date:  2020-02-24       Impact factor: 8.140

9.  Engineered Small-Molecule Control of Influenza A Virus Replication.

Authors:  Elizabeth J Fay; Stephanie L Aron; Ian A Stone; Barbara M Waring; Richard K Plemper; Ryan A Langlois
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

Review 10.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.